complic
sinus
lung
middl
ear
vurti
cli
usual
diagnos
basi
perceiv
signific
express
sign
symptom
ill
viral
symptom
sign
complex
vssc
summari
measur
degre
ill
defin
magnitud
durat
symptom
sign
element
typic
associ
vurti
vssc
element
similar
differ
causal
virus
believ
repres
overt
express
host
immun
inflammatori
respons
vurti
common
suggest
virus
provok
vssc
caus
cli
via
activ
similar
immun
inflammatori
pathway
cytokin
known
orchestr
coordin
host
immun
inflammatori
respons
vurti
exampl
assay
serial
nasal
wash
specimen
adult
subject
experiment
infect
rhinoviru
rsv
influenza
viru
coronaviru
document
consist
pattern
interleukin
interleukin
interleukin
interleukin
product
nasal
secret
tempor
track
vssc
respond
appropri
intervent
factor
modul
vssc
popul
individu
vurti
vssc
variabl
vurti
associ
cli
past
studi
document
varieti
factor
modul
vssc
consequ
cli
express
regard
latter
studi
natur
rsv
infect
infant
followup
studi
experiment
rsv
infect
adult
report
cc
genotyp
singlenucleotid
polymorph
promot
posit
associ
greater
vssc
primari
hypothesi
test
present
studi
genotyp
associ
greater
vssc
prolong
cli
experiment
infect
anoth
viru
rhinoviru
type
studi
rsv
also
document
effect
polymorph
interferon
g
ifng
tumor
necrosi
factor
tnfa
gene
immun
respons
complic
express
secondari
hypothesi
test
present
studi
polymorph
also
affect
host
respons
infect
healthi
adult
subject
recruit
advertis
protocol
studi
method
potenti
risk
explain
recruit
subject
written
inform
consent
studi
particip
human
immunodefici
viru
hiv
screen
obtain
gener
physic
examin
perform
health
histori
taken
recruit
screen
subject
exclud
medic
reason
standard
demograph
inform
collect
blood
drawn
total
differenti
blood
cell
count
clinic
chemic
analysi
assay
serum
neutral
antibodi
titer
hiv
antibodi
urin
collect
clinic
urinalysi
buccal
swab
collect
dna
isol
seventytwo
healthi
accord
histori
physic
examin
total
differenti
blood
cell
count
blood
chemistri
urin
profil
neg
test
result
hiv
antibodi
suscept
serum
antibodi
titer
adult
year
old
subject
enrol
two
day
admitt
cloister
day
blood
drawn
subject
repeat
assay
serum
neutral
antibodi
titer
subject
admit
cloister
site
confin
isol
floor
hotel
day
day
preexposur
period
day
sequenti
postexposur
period
day
femal
subject
posit
urin
pregnanc
test
result
exclud
subject
present
cli
end
day
subject
inocul
direct
instil
cours
drop
nasal
mucosa
estim
dose
time
median
tissu
cultur
infect
dose
day
cloister
subject
underw
gener
physic
examin
well
examin
ear
nose
throat
complet
symptom
diari
addit
nasal
mucociliari
clearanc
function
assess
nasal
secret
product
measur
nasal
wash
perform
sampl
aliquot
frozen
later
assay
throughout
studi
period
subject
permit
take
prescript
overthecount
medic
except
acetaminophen
dispens
studi
personnel
birth
control
drug
end
day
subject
interview
physician
provid
specif
instruct
followup
discharg
cloister
around
studi
day
convalesc
blood
sampl
drawn
subject
studi
protocol
inform
consent
form
approv
institut
review
board
univers
pittsburgh
carnegi
mellon
univers
virolog
challeng
viru
safetytest
strain
serum
neutral
antibodi
assay
screen
day
day
standard
dilut
method
titer
report
reciproc
final
dilut
seroconvers
defin
increas
titer
day
sampl
nasal
wash
fluid
subject
studi
day
place
volvol
cryovial
contain
concentr
viru
collect
broth
frozen
detect
sampl
thaw
ml
mixtur
inocul
tube
human
embryon
lung
fibroblast
cell
cell
observ
rhinoviru
cytopath
effect
infect
defin
detect
challeng
viru
day
variabl
repres
infect
durat
day
shed
construct
sum
day
isol
dna
isol
genotyp
phenotyp
assign
genom
dna
isol
buccal
cell
mean
qiaamp
dna
mini
kit
qiagen
amplifi
use
replig
whole
genom
amplif
kit
qiagen
quantifi
quantit
picogreen
dsdna
assay
kit
invitrogen
primer
probe
sequenc
cytokin
genotyp
assay
base
use
previou
public
tnfa
ifng
genotyp
perform
taqman
genotyp
master
mix
appli
biosystem
accord
publish
protocol
system
sd
softwar
version
appli
biosystem
use
instrument
control
autom
data
collect
genotyp
assign
phenotyp
correspond
vitro
cytokin
product
stimul
lymphocyt
assign
genotyp
use
convent
publish
gentil
colleagu
specif
gg
gc
genotyp
assign
highproduct
phenotyp
cc
lowproduct
phenotyp
tnfa
ga
aa
genotyp
assign
highproduct
phenotyp
gg
lowproduct
phenotyp
ifng
tt
genotyp
assign
highproduct
phenotyp
ta
intermediateproduct
phenotyp
aa
lowproduct
phenotyp
gccgcc
haplotyp
assign
highproduct
phenotyp
gccacc
gccata
intermediateproduct
phenotyp
accacc
acc
ata
ataata
lowproduct
phenotyp
ifng
phenotyp
code
low
product
intermedi
product
high
product
tnfa
phenotyp
code
low
product
high
product
protein
assay
one
aliquot
nasal
wash
fluid
collect
day
subject
thaw
assay
mean
commerci
avail
enzymelink
immunosorb
assay
biosourc
lower
detect
limit
assay
pgml
subject
summari
variabl
product
construct
log
baselineadjust
concentr
sum
postexposur
day
cloister
sum
valu
assign
valu
log
p
symptom
assess
thirteen
vssc
element
evalu
mean
selfcomplet
diari
studi
day
use
scale
none
mild
moder
sever
element
repres
symptom
domain
nasal
symptom
rhinorrhea
nasal
congest
sneez
throat
symptom
sore
throat
cough
gener
symptom
headach
malais
chill
sweat
fever
complic
symptom
earach
chest
congest
sinu
pain
element
baselin
score
day
subtract
score
postchalleng
day
summari
variabl
domain
total
symptom
score
calcul
sum
day
baselineadjust
score
contain
element
neg
sum
valu
assign
valu
daili
diari
includ
question
presenc
absenc
cold
continu
variabl
cold
day
construct
sum
ye
respons
day
object
sign
assess
cloister
day
subject
expel
nasal
secret
preweigh
tissu
seal
tissu
plastic
bag
known
weight
end
period
bag
expend
tissu
weigh
secret
weight
ie
nasal
secret
product
determin
subtract
nasal
mucociliari
clearanc
function
measur
place
ml
dy
saccharin
solut
bilater
onto
anterior
aspect
inferior
turbin
use
calibr
pipett
nasal
mucociliari
clearanc
time
calcul
differ
time
solut
place
time
subject
report
sweet
tast
summari
nasal
secret
product
mucociliari
clearanc
time
variabl
calcul
baselineadjust
sum
valu
day
summari
variabl
normal
distribut
data
logtransform
valu
assign
valu
log
p
data
analysi
continu
outcom
variabl
log
summari
nasal
secret
weight
mucociliari
clearanc
time
concentr
summari
nasal
throat
gener
complic
total
symptom
score
number
cold
day
presenc
absenc
seroconvers
treat
dichotom
outcom
variabl
potenti
predictor
variabl
consist
tnfa
ifng
phenotyp
day
titer
number
virusshed
day
age
year
race
white
code
race
code
sex
femal
code
male
code
determin
whether
variabl
statist
signific
predictor
continu
outcom
variabl
multipl
regress
analysi
use
determin
whether
variabl
statist
signific
predictor
seroconvers
logist
regress
use
relationship
log
baselineadjust
protein
concentr
continu
outcom
variabl
evalu
use
simpl
linear
regress
statist
procedur
perform
use
ncss
statist
packag
softwar
kaysvil
unless
otherwis
indic
data
present
mean
standard
deviat
enrol
subject
serum
titer
studi
day
defin
protocol
nonsuscept
addit
subject
recov
day
defin
uninfect
wild
virus
isol
nasal
secret
sampl
subject
buccal
sampl
avail
cytokin
genotyp
analysi
data
subject
elimin
data
set
remain
subject
male
white
mean
age
year
data
graphic
symptom
sign
virolog
assay
genotyp
data
ifng
tnfa
complet
subject
genotyp
assay
haplotyp
assay
fail
subject
respect
protein
concentr
nasal
secret
collect
studi
day
avail
subject
none
cytokin
genotyp
distribut
deviat
significantli
hardyweinberg
equilibrium
distribut
cytokin
phenotyp
follow
tnfa
high
low
product
high
low
product
ifng
high
intermedi
low
product
haplotyp
high
result
consid
signific
sex
fep
male
code
male
code
interleukin
phenotyp
lowproduct
phenotyp
code
highproduct
phenotyp
code
race
white
code
race
code
rhinoviru
type
se
standard
error
intermedi
low
product
number
subject
shed
viru
total
day
respect
day
antibodi
titer
defin
titer
subject
respect
thirtyfour
subject
seroconvert
mean
number
cold
day
day
statist
result
multipl
regress
analys
continu
outcom
variabl
present
tabl
list
predictor
age
p
signific
predictor
variabl
white
race
signific
predictor
higher
throat
symptom
score
male
sex
signific
predictor
cold
day
higher
throat
symptom
score
higher
total
symptom
score
margin
signific
predictor
greater
log
secret
weight
higher
baselin
titer
signific
predictor
fewer
cold
day
lower
nasal
throat
total
symptom
score
margin
signific
predictor
lower
complic
symptom
score
virusshed
day
signific
predictor
cold
day
greater
log
secret
weight
higher
summari
nasal
throat
complic
total
score
lowproduct
phenotyp
signific
predictor
cold
day
higher
gener
total
symptom
score
margin
signific
predictor
higher
nasal
complic
symptom
score
neither
tnfa
phenotyp
significantli
associ
outcom
variabl
figur
show
baselineadjust
mean
daili
symptom
score
domain
total
symptom
group
defin
lowand
highproduct
phenotyp
except
throat
symptom
score
mean
score
domain
total
symptom
greater
day
among
subject
lowproduct
phenotyp
ie
cc
compar
subject
highproduct
phenotyp
ie
cg
gg
multipl
regress
analysi
overspecifi
contribut
possibl
predictor
log
baselineadjust
total
protein
concentr
limit
possibl
predictor
cytokin
phenotyp
number
day
shed
baselin
titer
produc
signific
effect
variabl
outcom
mean
log
valu
outcom
variabl
lowand
highproduct
phenotyp
pgml
respect
betweengroup
differ
signific
p
p
student
test
figur
show
mean
log
concentr
function
studi
day
group
defin
phenotyp
curv
close
approxim
obviou
differ
studi
day
log
baselineadjust
total
protein
concentr
posit
correl
number
cold
day
r
p
p
summari
nasal
throat
r
p
p
r
p
gener
complic
p
p
r
p
p
p
r
p
figur
mean
daili
nasal
throat
gener
complic
total
symptom
score
mean
daili
concentr
interleukin
group
defin
lowproduct
white
circl
highproduct
black
circl
phenotyp
upper
horizont
bar
indic
mean
valu
lowproduct
phenotyp
plu
standard
error
lower
horizont
bar
indic
mean
valu
highproduct
phenotyp
minu
standard
error
total
symptom
score
p
p
r
p
p
log
secret
weight
r
p
p
p
vast
literatur
relat
cytokin
polymorph
variou
inflammatori
infecti
diseas
studi
examin
possibl
role
play
polymorph
modul
variou
express
vurti
one
studi
rsv
infect
hospit
infant
report
lowproduct
phenotyp
associ
greater
ill
sever
studi
experiment
rsv
infect
adult
report
lowproduct
phenotyp
associ
greater
vssc
result
present
studi
experiment
infect
adult
consist
find
support
primari
hypothesi
specif
lowproduct
phenotyp
predict
greater
vssc
greater
symptom
score
symptom
domain
subject
effect
realiz
across
postexposur
day
figur
although
phenotyp
effect
object
ill
measur
nasal
secret
product
mucociliari
clearanc
time
outcom
variabl
also
predict
phenotyp
adult
experiment
infect
rsv
result
studi
support
hypothesi
phenotyp
effect
vurti
express
reflect
frequenc
common
vurti
complic
otiti
media
specif
crosssect
studi
patel
colleagu
report
lowproduct
phenotyp
significantli
frequent
children
histori
recurr
acut
otiti
media
compar
children
without
histori
otiti
media
longitudin
studi
young
children
alper
colleagu
report
lowproduct
phenotyp
signific
predictor
otiti
media
coincid
rate
rhinoviru
infect
second
object
studi
explor
effect
tnfa
ifng
polymorph
host
respons
infect
polymorph
shown
affect
host
respons
rsv
infect
rate
vurti
complic
outcom
examin
studi
ifng
polymorph
shown
signific
effect
phenotyp
invers
predictor
rate
seroconvers
infect
adult
experiment
infect
rsv
tnfa
phenotyp
directli
relat
frequenc
seroconvers
wherea
ifng
phenotyp
indirectli
relat
frequenc
subject
develop
increas
nasal
rsvspecif
secretori
immunoglobulin
antibodi
titer
present
studi
lack
signific
effect
cytokin
polymorph
may
explain
primari
effect
previou
studi
vurti
complic
frequenc
otiti
media
pneumonia
event
observ
present
studi
result
suffici
evid
advanc
hypothesi
cc
genotyp
lowproduct
phenotyp
associ
upregul
inflammatori
respons
vurti
reflect
vssc
frequenc
express
complic
although
mechan
polymorph
exert
effect
remain
elus
given
complex
poorli
understood
tempor
interact
among
variou
cytokin
inflammatori
chemic
provok
vssc
express
vurti
simplest
hypothesi
reject
specif
report
past
studi
higher
nasal
concentr
posit
correl
phase
magnitud
express
vssc
lead
expect
highproduct
phenotyp
would
predict
higher
nasal
concentr
consequ
greater
ill
magnitud
howev
neither
expect
support
experiment
data
statist
signific
relationship
demonstr
phenotyp
local
nasal
secret
concentr
either
experiment
experiment
rsv
infect
adult
studi
review
lowproduct
highproduct
phenotyp
predict
greater
ill
complic
interpret
result
recogn
cytokin
phenotyp
assign
basi
vitro
result
stimul
cytokin
releas
leukocyt
may
may
relat
vivo
cytokin
product
nasal
mucosa
blood
local
secret
vurti
moreov
larg
number
polymorph
gene
cytokin
assay
present
studi
potenti
interact
assay
polymorph
influenc
cytokin
product
past
studi
shown
local
product
specif
cytokin
influenc
polymorph
gene
cytokin
eg
tnfa
polymorph
predict
protein
concentr
nasal
secret
observ
emphas
difficulti
predict
cytokin
product
biolog
compart
respons
vurti
use
genotypephenotyp
associ
given
cytokin
polymorph
basi
vitro
studi
conclus
present
studi
document
statist
signific
effect
certain
cytokin
polymorph
select
express
infect
limit
studi
includ
rel
cytokin
polymorph
assay
assay
protein
nasal
secret
restrict
outcom
seroconvers
provok
symptom
object
measur
ill
addit
studi
limit
adult
frequenc
vurti
complic
low
effect
cytokin
polymorph
complic
frequenc
could
assess
nonetheless
highli
like
continu
studi
cytokin
polymorph
set
natur
experiment
vurti
yield
import
inform
regard
genet
basi
cli
vurti
vurti
complic
